Ninety One UK Ltd Sells 22,967 Shares of Stericycle, Inc. (NASDAQ:SRCL)

Ninety One UK Ltd lessened its stake in Stericycle, Inc. (NASDAQ:SRCL) by 4.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 483,491 shares of the business services provider’s stock after selling 22,967 shares during the period. Ninety One UK Ltd owned approximately 0.52% of Stericycle worth $23,962,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Stericycle by 9.2% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 19,737 shares of the business services provider’s stock worth $978,000 after acquiring an additional 1,659 shares during the period. Louisiana State Employees Retirement System purchased a new position in Stericycle in the fourth quarter worth about $1,289,000. NewEdge Wealth LLC bought a new stake in shares of Stericycle during the 4th quarter valued at about $322,000. Cerity Partners LLC increased its position in shares of Stericycle by 145.0% during the 4th quarter. Cerity Partners LLC now owns 33,532 shares of the business services provider’s stock valued at $1,662,000 after purchasing an additional 19,846 shares during the last quarter. Finally, Seelaus Asset Management LLC bought a new position in shares of Stericycle in the 4th quarter worth approximately $299,000. 98.82% of the stock is currently owned by hedge funds and other institutional investors.

Stericycle Trading Up 0.3 %

Shares of Stericycle stock opened at $48.87 on Friday. Stericycle, Inc. has a fifty-two week low of $37.78 and a fifty-two week high of $57.06. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.94 and a current ratio of 0.94. The company has a market capitalization of $4.53 billion, a P/E ratio of -203.63, a P/E/G ratio of 2.64 and a beta of 1.09. The company has a fifty day moving average of $51.39 and a 200 day moving average of $47.91.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Wednesday, February 28th. The business services provider reported $0.54 EPS for the quarter, beating the consensus estimate of $0.47 by $0.07. Stericycle had a positive return on equity of 7.06% and a negative net margin of 0.80%. The business had revenue of $652.00 million for the quarter, compared to the consensus estimate of $657.99 million. During the same period in the previous year, the business earned $0.60 earnings per share. The business’s revenue was down 2.7% on a year-over-year basis. On average, sell-side analysts anticipate that Stericycle, Inc. will post 2.31 earnings per share for the current fiscal year.

Analysts Set New Price Targets

SRCL has been the subject of a number of research reports. Stifel Nicolaus upped their target price on shares of Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a report on Thursday, February 29th. Wells Fargo & Company raised their target price on Stericycle from $40.00 to $48.00 and gave the stock an “underweight” rating in a report on Friday, March 1st. Royal Bank of Canada reissued an “outperform” rating and set a $69.00 price target on shares of Stericycle in a report on Thursday, March 7th. StockNews.com downgraded Stericycle from a “buy” rating to a “hold” rating in a research note on Tuesday, April 2nd. Finally, Truist Financial lifted their price objective on Stericycle from $50.00 to $57.00 and gave the company a “hold” rating in a research report on Thursday, February 29th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, Stericycle presently has an average rating of “Hold” and an average price target of $62.25.

Stericycle Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.